Myesha Lacy
Profile
Myesha Lacy worked as a VP of Investor Relations & Corporate Communications at Global Blood Therapeutics, Inc. and Adverum Biotechnologies, Inc. before obtaining an undergraduate degree from Holy Names University.
Former positions of Myesha Lacy
| Companies | Position | End |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Investor Relations Contact | - |
| ADVERUM BIOTECHNOLOGIES, INC. | Investor Relations Contact | - |
Training of Myesha Lacy
| Holy Names University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Myesha Lacy
